[1] EUROPEAN COMMISSION, DIRECTORATE-GENERAL FOR INTERNAL MARKET, INDUSTRY, ENTREPRENEURSHIP AND SMEs. Amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use in cosmetic products of certain substances classified as carcinogenic, mutagenic or toxic for reproduction and correcting that Regulation[EB/OL].(2022-09-15). https: //eur-lex.europa. eu/legal-content/EN/TXT/HTML/?uri=CELEX: 32022R1531. [2] DEPARTMENT FOR BUSINESS AND TRADE. The cosmetic products (restriction of chemical substances) regulations 2025[EB/OL]. (2025-03-27). https: //www.legislation.gov.uk/uksi/ 2025/413/contents/made. [3] DAVISON C, SMITH P K, ZIMMERMAN E F. On the metabolism and toxicity of methyl salicylate[J]. J Pharmacol Exp Ther, 1961, 132(2): 207-211. [4] TELAPROLU K C, GRICE J E, MOHAMMED Y H, et al. Human skin drug metabolism: relationships between methyl salicylate metabolism and esterase activities in IVPT skin membranes[J]. Metabolites, 2023, 13(8): 934. [5] ROSENBLOOM J. A case of acute methyl salicylate poisoning [J]. J Am Med Assoc, 1919, 72(1): 22. [6] STEVENS D L. Salicylate intoxication in children: report of four cases[J]. Am J Dis Child, 1945, 70(5): 331. [7] LAFORET E G, COLLINS W V. Acute fatal methyl salicylate toxicity: report of a case[J]. Conn State Med, 1946, 10: 196-202. [8] BELL A J, DUGGIN G. Acute methyl salicylate toxicity complicating herbal skin treatment for psoriasis[J]. Emerg Med, 2002, 14(2): 188-190. [9] COSMETIC INGREDIENT REVIEW EXPERT PANEL. Safety assessment of salicylic acid, butyloctyl salicylate, calcium salicylate, C12-15 alkyl salicylate, capryloyl salicylic acid, hexyldodecyl salicylate, isocetyl salicylate, isodecyl salicylate, magnesium salicylate, MEA-Salicylate, ethylhexyl salicylate, potassium salicylate, methyl salicylate, myristyl salicylate, sodium salicylate, TEA-salicylate, and tridecyl salicylate[J]. Int J Toxicol, 2003, 22(3 Sup): 1-108. [10] LI S Y, LIU X J, ZHANG Y L, et al. Determination of seven restricted halogenated salicylanilides in cosmetics by high performance liquid chromatography[J]. Anal Methods, 2016, 8(25): 5129-5135. [11] SCIENTIFIC COMMITTEE ON CONSUMER SAFETY. Scientific advice on methyl salicylate (methyl 2-hydroxybenzoate) -children exposure, version of 17 January 2025, final version of 30 April 2025, SCCS/1676/25[EB/OL].(2025-05-02).https: // health.ec.europa.eu/publications/scientific-advice-childrens-exposure-methyl-salicylate-methyl-2-hydroxybenzoate-revision -sccs165423_en. [12] ITAMI T, KANOH S. Studies on the pharmacological bases of fetal toxicity of drugs (iv). effect of endotoxin and starvation on serum protein binding of salicylic acid in pregnant rats[J]. Jpn J Pharmacol, 1983, 33(6): 1199-1204. [13] DAVIS J E. Are one or two dangerous? Methyl salicylate exposure in toddlers[J]. J Emerg Med, 2007, 32(1): 63-69. [14] EUROPEAN UNION. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products[J]. Off J Eur Communities, 2009: 13-14. [15] COSMETIC INGREDIENT REVIEW. CIR Ingredient Status Report.[EB/OL]. (2019-04-09). https: //cir-reports.cir-safety.org/ cir-ingredient-status-report/ id=8eae2a14-6fa9-437a-882f-414 fe4be68c5. [16] 中华人民共和国国家食品药品监督管理总局.国家食品药品监督管理总局关于发布已使用化妆品原料名称目录(2015版)的通告(2015年第105号) [EB/OL]. (2015-12-23). https: //www.nmpa.gov.cn/directory/web/nmpa/xxgk/ggtg/hzhpggtg/ jmhzhptg/20151223120001361.html. [17] 中华人民共和国国家食品药品监督管理总局. 总局关于实施化妆品安全技术规范(2015年版)有关事宜的公告(2016年第 108号) [EB/OL]. (2016-06-01). https: //www.nmpa.gov.cn/ directory/web/nmpa/xxgk/ggtg/hzhpggtg/jmhzhptg/20160601173701337.html. [18] GOVERNMENT OF CANADA. Cosmetic Ingredient Hotlist.[EB/ OL]. (2025-08-13). https: //www.canada.ca/en/health-canada/ services/consumer-product-safety/cosmetics/cosmetic-ingredienthotlist-prohibited-restricted-ingredients/hotlist.html. [19] AUSTRALIAN INDUSTRIAL CHEMICALS INTRODUCTION SCHEME. Salicylic acid and its salts. [EB/OL].(2024-03-22). https://www.industrialchemicals.gov.au/sites/default/files/2024-06/EVA00136%20-%20Evaluation%20Statement%20-%2026% 20June%202024.pdf. [20] THERAPEUTIC GOODS ADMINISTRATION. AU Q00531, AU D00981, (Revocation of a TGA certificate under section 41ES of the Therapeutic Goods Act 1989) [EB/OL].(2025-03-05). https: //www.tga.gov.au/resources/cancellations-suspensions/au-q00531-au-d00981-revocation-tga-certificate-undersection-41es-therapeutic-goods-act-1989. [21] 夏泽敏, 李传茂, 贾芳, 等. 皂基化妆品中水杨酸质量问题成因分析及风险探讨[J].日用化学品科学, 2022, 45(6): 39-42. |